FDA to Hold DTC Hearing in November

The FDA will hold a public hearing November 1 and 2 to discuss the issue of direct-to-consumer pharmaceutical advertising, AdAge reports. While the last public hearings on DTC advertising didn't produce any guidelines to regulate the category, the consensus is that this time, the FDA will "produce something of substance," according to a chief marketing officer for a major drug maker.